| 301 |
24009772 | Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts. | 2013 |
1 |
| 302 |
24180199 | [Metformin, an antidiabetic molecule with anti-cancer properties]. | 2013 Sep |
1 |
| 303 |
24335168 | Metformin inhibits esophagus cancer proliferation through upregulation of USP7. | 2013 |
1 |
| 304 |
24351837 | The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo. | 2013 Dec 18 |
3 |
| 305 |
22080879 | LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells. | 2012 Jan |
2 |
| 306 |
22252099 | Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway. | 2012 May |
3 |
| 307 |
22343549 | Intracerebroventricular administration of metformin inhibits ghrelin-induced Hypothalamic AMP-kinase signalling and food intake. | 2012 |
2 |
| 308 |
22378068 | Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. | 2012 Mar 1 |
3 |
| 309 |
22389381 | Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. | 2012 Jun |
2 |
| 310 |
22406476 | Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. | 2012 Jun |
1 |
| 311 |
22443173 | Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial. | 2012 Mar 26 |
2 |
| 312 |
22469973 | Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway. | 2012 Jun |
3 |
| 313 |
22490993 | Does use of metformin protect against cancer in Type 2 diabetes mellitus? | 2012 Feb |
1 |
| 314 |
22500211 | Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells. | 2012 |
2 |
| 315 |
22540890 | Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway. | 2012 Sep-Oct |
3 |
| 316 |
22593441 | Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. | 2012 May |
1 |
| 317 |
22611195 | Distinct perturbation of the translatome by the antidiabetic drug metformin. | 2012 Jun 5 |
2 |
| 318 |
22659796 | Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells. | 2012 Jun 15 |
1 |
| 319 |
22735790 | Metformin impairs the growth of liver kinase B1-intact cervical cancer cells. | 2012 Oct |
2 |
| 320 |
22863784 | Effect of advanced glycation end products on lectin-like oxidized low density lipoprotein receptor-1 expression in endothelial cells. | 2012 |
1 |
| 321 |
22994747 | Metformin inhibits growth of hepatocellular carcinoma cells by inducing apoptosis via mitochondrion-mediated pathway. | 2012 |
1 |
| 322 |
23151022 | In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma. | 2012 Nov 14 |
1 |
| 323 |
23525940 | One-carbon metabolism: an aging-cancer crossroad for the gerosuppressant metformin. | 2012 Dec |
1 |
| 324 |
21084384 | Interaction of glibenclamide and metformin at the level of translation in pancreatic β cells. | 2011 Feb |
4 |
| 325 |
21168492 | Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells. | 2011 Sep |
2 |
| 326 |
21262823 | Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. | 2011 Feb 8 |
1 |
| 327 |
21270604 | Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression. | 2011 Feb |
2 |
| 328 |
21349801 | Metformin: its emerging role in oncology. | 2011 Jan-Mar |
1 |
| 329 |
21465524 | Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells. | 2011 May |
2 |
| 330 |
21470407 | Understanding the benefit of metformin use in cancer treatment. | 2011 Apr 6 |
2 |
| 331 |
21532889 | Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. | 2011 May |
1 |
| 332 |
21540236 | Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. | 2011 Jul 1 |
4 |
| 333 |
21552292 | Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation. | 2011 Jul |
2 |
| 334 |
21631893 | Metformin as an antitumor agent in cancer prevention and treatment. | 2011 Dec |
2 |
| 335 |
21655990 | Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. | 2011 Aug |
1 |
| 336 |
21680296 | Metformin: a new option in cancer treatment. | 2011 Jun |
2 |
| 337 |
21840335 | Caloric restriction. | 2011 Jun |
1 |
| 338 |
22015290 | Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin. | 2011 Oct |
1 |
| 339 |
22021366 | Antileukemic effects of AMPK activators on BCR-ABL-expressing cells. | 2011 Dec 8 |
1 |
| 340 |
22067284 | Genome protective effect of metformin as revealed by reduced level of constitutive DNA damage signaling. | 2011 Oct |
2 |
| 341 |
22203527 | Metformin: multi-faceted protection against cancer. | 2011 Dec |
1 |
| 342 |
19822355 | Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy. | 2010 Jan |
1 |
| 343 |
20126541 | Metabolic regulation of neuronal plasticity by the energy sensor AMPK. | 2010 Feb 1 |
1 |
| 344 |
20135346 | Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. | 2010 Aug |
2 |
| 345 |
20363874 | AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. | 2010 Jun |
2 |
| 346 |
20465505 | Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. | 2010 May |
1 |
| 347 |
20564343 | Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase. | 2010 Jul |
1 |
| 348 |
20668229 | The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation. | 2010 Nov 18 |
2 |
| 349 |
20810671 | Chemoprevention meets glucose control. | 2010 Sep |
1 |
| 350 |
21098287 | Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. | 2010 Dec 14 |
1 |